TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Somnomed Limited ( (AU:SOM) ) is now available.
Somnomed Limited has announced the issuance of unquoted equity securities, specifically options with varying expiration dates and exercise prices. This move is likely to impact the company’s financial strategy and market positioning by potentially increasing its capital base and providing incentives for stakeholders.
The most recent analyst rating on (AU:SOM) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Somnomed Limited stock, see the AU:SOM Stock Forecast page.
More about Somnomed Limited
Somnomed Limited operates in the healthcare industry, specializing in the development and distribution of oral appliances for the treatment of sleep-related disorders, particularly obstructive sleep apnea.
Average Trading Volume: 373,921
Technical Sentiment Signal: Buy
Current Market Cap: A$176.7M
For an in-depth examination of SOM stock, go to TipRanks’ Overview page.